We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+0.62%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$720M
AUM Growth
-$59.6M
Cap. Flow
-$36.5M
Cap. Flow %
-5.06%
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.08M
2
JBTM
JBT Marel
JBTM
+$3.91M
3
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
+$3.66M
4
NOG icon
Northern Oil and Gas
NOG
+$3.45M
5
DVN icon
Devon Energy
DVN
+$3.09M

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$7.07M
2
RS icon
Reliance Steel & Aluminium
RS
+$5.93M
3
CHX
ChampionX
CHX
+$4.74M
4
ACN icon
Accenture
ACN
+$4.11M
5
ONON icon
On Holding
ONON
+$3.96M

Sector Composition

Rank Sector Weight
1 Technology 21.49%
2 Consumer Discretionary 17.64%
3 Industrials 15.79%
4 Healthcare 11.67%
5 Financials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
376
Regeneron Pharmaceuticals
REGN
$70.6B
$298K 0.04%
362
-10
-3% -$7.86K
CB icon
377
Chubb
CB
$139B
$297K 0.04%
1,426
-1
-0.1% -$202
FCX icon
378
Freeport-McMoran
FCX
$89.2B
$296K 0.04%
+7,934
New +$320K
BLDR icon
379
Builders FirstSource
BLDR
$7.83B
$295K 0.04%
2,371
-749
-24% -$103K
UL icon
380
Unilever
UL
$132B
$295K 0.04%
5,309
-1,322
-20% -$76.4K
GIS icon
381
General Mills
GIS
$19.6B
$294K 0.04%
4,601
+893
+24% +$63.1K
MS icon
382
Morgan Stanley
MS
$335B
$287K 0.04%
3,519
+1,054
+43% +$91.5K
BLK icon
383
Blackrock
BLK
$164B
$286K 0.04%
443
+14
+3% +$9.78K
GILD icon
384
Gilead Sciences
GILD
$164B
$285K 0.04%
3,809
-1,124
-23% -$86.5K
HLIT icon
385
Harmonic Inc
HLIT
$1.19B
$284K 0.04%
29,481
-3,180
-10% -$37.9K
BBDC icon
386
Barings BDC
BBDC
$871M
$283K 0.04%
31,720
-4,117
-11% -$35.4K
ADI icon
387
Analog Devices
ADI
$179B
$281K 0.04%
1,606
+480
+43% +$88.5K
MU icon
388
Micron Technology
MU
$980B
$279K 0.04%
4,105
+175
+4% +$11.7K
TRIN icon
389
Trinity Capital
TRIN
$1.56B
$276K 0.04%
19,833
-2,054
-9% -$29.8K
KBR icon
390
KBR
KBR
$4.7B
$274K 0.04%
4,643
-1,140
-20% -$70.2K
EOG icon
391
EOG Resources
EOG
$75.6B
$273K 0.04%
+2,154
New +$274K
CRWD icon
392
CrowdStrike
CRWD
$186B
$271K 0.04%
6,488
– –
CME icon
393
CME Group
CME
$92.4B
$269K 0.04%
1,343
-55
-4% -$10.9K
LVS icon
394
Las Vegas Sands
LVS
$31.6B
$263K 0.04%
+5,735
New +$310K
ZTS icon
395
Zoetis
ZTS
$32.3B
$263K 0.04%
+1,511
New +$274K
SO icon
396
Southern Company
SO
$109B
$260K 0.04%
4,011
+4
+0.1% +$278
BDX icon
397
Becton Dickinson
BDX
$44.1B
$260K 0.04%
1,004
-49
-5% -$13.2K
MDB icon
398
MongoDB
MDB
$25.1B
$258K 0.04%
747
– –
AXNX
399
DELISTED
Axonics, Inc. Common Stock
AXNX
$258K 0.04%
+4,602
New +$259K
PCOR icon
400
Procore
PCOR
$6.91B
$257K 0.04%
3,934
– –
14 15
16
17 18

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

Advisory Research's Q3 2023 Portfolio in Review

As of Q3 2023, Advisory Research held 510 positions worth $720M, down 7.6% from $780M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research withdrew a net $36.5M in Q3 2023, closing 86 positions and reducing 203 holdings. Its most notable exit was Livent Corporation, an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Advisory Research opened a new position in JBT Marel worth $3.67M.

  • Advisory Research's largest Q3 2023 buy was JBT Marel: 34,900 shares worth $3.67M.
  • Advisory Research added most to GSK in Q3 2023, an estimated $4.08M increase.
  • Advisory Research's biggest Q3 2023 reduction was Denbury Inc., cutting an estimated $7.07M.
  • Advisory Research fully exited Livent Corporation in Q3 2023, selling an estimated $2.81M.
  • Advisory Research's ten largest holdings make up 17% of its $720M portfolio in Q3 2023.
  • Advisory Research opened 74 new positions and closed 86 in Q3 2023.
  • Advisory Research's portfolio value fell 7.6% quarter-over-quarter to $720M.

Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.